ERT, the global leader in clinical endpoint data collection, highlights MasterScopeTM Pulmonary Function Testing (PFT) platform’s new features and functionality for respiratory clinical trials.
Its highly intuitive, multi-language user interface, study-specific quality control procedures, customized protocol workflows, and other smart features such as the unique biometric user identification (21 CFR Part 11 compliant) make it the preferred choice for studies using Spirometry, ECG, FeNO, Oscillometry, and more. With multi-protocol support and device reuse options, MasterScope also minimizes equipment costs and logistics, speeds trial start-up, and eases investigative site burden. Its precise, disposable, and pre-calibrated Pneumotach sensor eliminates time-consuming daily calibration.
Achim Schülke, Executive Vice President, ERT Respiratory Solutions, said: “Concerns about increased demand for hygiene and distancing are still real amid this continuing global pandemic. Our responsibility is to make the patient and operator experience at clinical trial sites as safe and comfortable as possible. And by using the same sensor in both the MasterScope and SpiroSphere, we are providing a harmonized, streamlined experience to our customers.”
